The FDA alerts health care providers about potential risks with liquid-filled intragastric balloons

The FDA has recently received multiple reports for two different types of adverse events associated with liquid-filled intragastric balloons used to treat obesity. The first type of adverse event involves balloon over-inflating and the second type is development of acute pancreatitis.

 
comments powered by Disqus